ATE301671T1 - Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta - Google Patents

Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta

Info

Publication number
ATE301671T1
ATE301671T1 AT97932092T AT97932092T ATE301671T1 AT E301671 T1 ATE301671 T1 AT E301671T1 AT 97932092 T AT97932092 T AT 97932092T AT 97932092 T AT97932092 T AT 97932092T AT E301671 T1 ATE301671 T1 AT E301671T1
Authority
AT
Austria
Prior art keywords
determining
brain
beta
specific protein
thr82
Prior art date
Application number
AT97932092T
Other languages
English (en)
Inventor
Jan Brundell
Lena Nyberg
Original Assignee
Diasorin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diasorin Ab filed Critical Diasorin Ab
Application granted granted Critical
Publication of ATE301671T1 publication Critical patent/ATE301671T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97932092T 1996-07-05 1997-06-27 Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta ATE301671T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602677A SE9602677D0 (sv) 1996-07-05 1996-07-05 Methods for determining brain antigens
PCT/SE1997/001164 WO1998001471A1 (en) 1996-07-05 1997-06-27 Methods for determining the presence of brain protein s-100

Publications (1)

Publication Number Publication Date
ATE301671T1 true ATE301671T1 (de) 2005-08-15

Family

ID=20403304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932092T ATE301671T1 (de) 1996-07-05 1997-06-27 Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta

Country Status (13)

Country Link
EP (1) EP0931094B1 (de)
JP (1) JP2000515854A (de)
AT (1) ATE301671T1 (de)
AU (1) AU715797B2 (de)
BR (1) BR9710175A (de)
CA (1) CA2259413A1 (de)
DE (1) DE69733957T2 (de)
ES (1) ES2247633T3 (de)
IL (1) IL127278A0 (de)
NO (1) NO986218D0 (de)
NZ (1) NZ333408A (de)
SE (1) SE9602677D0 (de)
WO (1) WO1998001471A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4527286B2 (ja) * 1998-08-28 2010-08-18 カンナグ ディアグノスティクス エイビー サンプル中のＳ１００αβおよびＳ１００ββの総量を定量する方法、サンプル中のＳ１００ββの量を定量する方法、サンプル中のＳ１００αβの量を定量する方法、Ｓ１００ββの量をアッセイするためのキット、Ｓ１００αβの量をアッセイするためのキット、ハイブリドーマ細胞系Ｓ１０：３、ハイブリドーマ細胞系Ｓ３５：２、及びハイブリドーマ細胞系Ｓ２３：２
AU773265B2 (en) * 1998-11-05 2004-05-20 Regents Of The University Of Michigan, The S100 proteins and autoantibodies as serum markers for cancer
US6780606B1 (en) 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2263063C (en) 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel
WO2001096878A2 (en) * 2000-06-14 2001-12-20 University Of Zurich Marker for neurodegerative diseases and its use in drug screening
ES2394331B2 (es) * 2011-06-17 2013-07-15 Universidade De Santiago De Compostela Uso de un péptido antigénico aislado derivado de la proteína s100-beta no unido a una molécula mhc de clase ii en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i
ES2394972B2 (es) * 2011-06-17 2013-07-19 Universidade De Santiago De Compostela Péptido antigénico aislado derivado de la proteína s100-beta, procedimiento de identificación y su uso en la prevención, tratamiento, diagnóstico y/o seguimiento de la diabetes tipo i.
CN102331502B (zh) * 2011-08-31 2013-12-04 内蒙古科慧生物科技有限责任公司 人s100蛋白(s-100)定量测定试剂盒
WO2014194329A1 (en) * 2013-05-31 2014-12-04 Banyan Biomarkers, Inc. NEURAL SPECIFIC S100β FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
CN111487409A (zh) * 2019-01-28 2020-08-04 艾维可生物科技有限公司 一种s100b蛋白的化学发光法检测试剂盒及其使用方法

Also Published As

Publication number Publication date
WO1998001471A1 (en) 1998-01-15
CA2259413A1 (en) 1998-01-15
BR9710175A (pt) 2000-01-11
JP2000515854A (ja) 2000-11-28
ES2247633T3 (es) 2006-03-01
NO986218L (no) 1998-12-30
AU715797B2 (en) 2000-02-10
NO986218D0 (no) 1998-12-30
DE69733957T2 (de) 2006-04-13
SE9602677D0 (sv) 1996-07-05
AU3563397A (en) 1998-02-02
NZ333408A (en) 1999-05-28
IL127278A0 (en) 1999-09-22
EP0931094B1 (de) 2005-08-10
DE69733957D1 (de) 2005-09-15
EP0931094A1 (de) 1999-07-28

Similar Documents

Publication Publication Date Title
ATE140963T1 (de) Verfahren zur herstellung von sekretierten rezeptoranalogen
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
NO20014584D0 (no) Proteinisolering og -analyse
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
NL300118I2 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ATE301671T1 (de) Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta
KR970700772A (ko) T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법(t cell antigen receptor v region proteins and methods of preparation thereof)
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
DE60129239D1 (de) Kit und verfahren zur bestimmung von protein esm-1
ATE130102T1 (de) Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu.
BR9713450A (pt) Quimiocinas de mamìfero
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
SE9002212D0 (sv) Igg binding protein
DE69016858D1 (de) Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma.
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
EP0295719A3 (de) SM-D-Antigen, Klonierung von SM-D-Antigen und Nachweis von systemischen Lupus Erythematoden durch Benutzung von SM-D-Antigen
Lloyd et al. The antigenic constituents of cattle skin washings
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
ATE86747T1 (de) Die sm-b/b1-antigene, das klonen der sm-b/b1antigene und der nachweis von systemischem lupus erythematosus unter verwendung der sm b/b1- antigene.
SE8803986D0 (sv) Method for sequencing peptides or proteins
DE60041985D1 (de) Zusammensetzungen und verfahren zur erfassung von stress induzierten proteinen
DE3783840D1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.
ATE85087T1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.
HUP9902836A2 (hu) Eljárások az S-100 jelű agyi fehérje meghatározására

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties